Immuron (IMRN) Return on Capital Employed (2019 - 2024)

Immuron (IMRN) posted quarterly Return on Capital Employed of 56844044230936.93% for Q4 2024, up 5684404439541870.0% year-on-year from N/an in Q1 2024, and up 34559481317.57% on a QoQ basis from 164481.76% in Q4 2023.

Immuron (IMRN) Return on Capital Employed (2019 - 2024) Analysis & Trends

Immuron (IMRN) has reported Return on Capital Employed for 5 consecutive years, with 56844044230936.93% the latest figure, recorded in Q4 2024.

  • Quarterly Return on Capital Employed rose 5684404439541870.0% year-over-year to 56844044230936.93% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 56844044230936.93% (up 5684404439541870.0% YoY) and the FY2025 annual result came in at 166.56%, down 13627.0% from the prior year.
  • Return on Capital Employed improved to 56844044230936.93% in Q4 2024 per IMRN's latest filing, from 164481.76% in the prior quarter.
  • Over the last five years, Return on Capital Employed for IMRN reached as high as 56844044230936.93% in Q4 2024 and fell as low as 316943.11% in Q4 2021.
  • A 4-year average of 11368808677318.68% and a median of 170070.46% in 2022 frame the typical range for Return on Capital Employed.
  • Annual changes were most pronounced in 2023 — Return on Capital Employed surged 558870 bps — and 2024, when it jumped 2000000000 bps.
  • Year by year, Return on Capital Employed stood at 316943.11% in 2021, then jumped by 46 bps to 170070.46% in 2022, then rose by 3 bps to 164481.76% in 2023, then jumped by 2000000000 bps to 56844044230936.93% in 2024.
  • According to Business Quant data, Return on Capital Employed over the past three periods registered 56844044230936.93%, 164481.76%, and 192848.19% for Q4 2024, Q4 2023, and Q2 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -31.80%
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.46%
4 NuCana 279.75 Bn 279.75 Bn - -68.47%
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 10.19%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -68.84%
10 Immuron 270.20 Mn 258.54 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 56,844,044,230,936.93%
Dec 31, 2023 -164,481.76%
Jun 30, 2023 -192,848.19%
Dec 31, 2022 -170,070.46%
Dec 31, 2021 -316,943.11%
Dec 31, 2019 -352,613.62%